Sort
130,381 grants matching “hiv”
Identification of the Initial Targets of Transmission
$910,732Thomas Hope · Northwestern University At Chicago · R37 · FY2022 · AI
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK
$910,700University Of Miami Coral Gables · R01 · FY2003 · DA
Administrative Core
$910,638Robert Kernachan Heaton · University Of California, San Diego · P30 · FY2017 · MH
Mali International Center for Excellence in Research: Malaria immunology
$910,590Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Structure-Based Design of Drugs and Vaccines for Target*
$910,534Rutgers The St Univ Of Nj New Brunswick · P01 · FY2003 · GM
Structural Biology Core
$910,511Dmitry Lyumkis · Seattle Children'S Hospital · U54 · FY2025 · AI
Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells
$910,463David D Ho · Aaron Diamond Aids Research Center · R01 · FY2018 · AI
RAPID VACCINATION OF HARD TO REACH POPULATI0NS
$910,460New York Academy Of Medicine · R01 · FY2005 · DA
Point-of-care virologic testing to improve outcomes of HIV-infected children
$910,446Jeffrey S Stringer · Univ Of North Carolina Chapel Hill · U01 · FY2013 · AI
Consultation and Collaboration
$910,442Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Pragmatic Efficacy Trial of mHealth to Improve HIV Outcomes in the DC Cohort
$910,434Amanda Derryck Castel · George Washington University · R01 · FY2020 · MH
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$910,425Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA
SUPPORT OF TRAINING OF HIV HEALTH CARE PROVIDERS IN THE REPUBLIC OF BOTSWANA UNDE
$910,413Tendani Gaolathe · Botswana-Harvard Aids Institute · U2G · FY2010 · PS
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
$910,391Mark D Macek · University Of Maryland Baltimore · R01 · FY2023 · DE
A Multimedia HIV/STI Intervention for Black Drug-involved Women on Probation
$910,332Louisa Gilbert · Columbia Univ New York Morningside · R01 · FY2017 · DA
HIV EVALUATION ACTIVITIES WITH HIGH-RISK, UNDERSERVED POPULATIONS IN SOUTH AFRICA
$910,265Tim Lane · University Of California, San Francisco · U2G · FY2011 · GH
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.
$910,251Susan Gail Sherman · Johns Hopkins University · R01 · FY2024 · DA
Developing a Novel Incubator to Increase Cell Culture Reproducibility
$910,185Barry E. Rothenberg · Embrient Inc · R44 · FY2024 · TR
Intervention for Sustained Testing and Retention (iSTAR) Among HIV-infected Patients
$910,125Echezona Edozie Ezeanolue · University Of Nevada Las Vegas · R01 · FY2017 · HD
Substance Use and Immunity in HIV+ Adolescents by Systems Biology
$910,091Maureen M Goodenow · University Of Florida · R01 · FY2011 · DA
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection
$910,053Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · AI
PROPOSAL TO CONDUCT SURVEY DETERMINE IMPACT OF HIV PREVENTION BIOMED INTERVENTION
$910,000Cherie Anne Cawood · Epicentre Aids Risk Mgmt (Pty), Ltd · U2G · FY2014 · GH
STRENGTHEN BRAZIL'S NATIONAL RESPONSE TO HIV AND OTHER DISEAS
$909,999Marly Marques Da Cruz · Fundacao Oswaldo Cruz · U2G · FY2014 · GH
Antiviral role of CD8+T cells in ART-treated SIV-infected macaques
$909,998Guido Silvestri · Emory University · R01 · FY2023 · AI
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles
$909,998Rui Kong · Emory University · R01 · FY2024 · AI